Pfizer Inc.(PFE)
Pharmaceuticals
Large-Cap Diversified Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-10 | DAMICO JENNIFER B. SVP & Controller | Sale | -2,000 | -5.99%31,397 | $25.70 | $51,400 | View SEC filing | |
| 2025-03-06 | DAMICO JENNIFER B. SVP & Controller | Sale | -2,500 | -17.42%11,850 | $25.93 | $64,825 | View SEC filing | |
| 2025-02-14 | BLAYLOCK RONALD E Director | Purchase | +19,457 | +235.84%27,707 | $25.65 | $499,072 | View SEC filing | |
| 2024-10-31 | Gottlieb Scott Director | Purchase | +1,000 | +11.11%10,000 | $28.24 | $28,240 | View SEC filing | |
| 2024-08-14 | DAMICO JENNIFER B. SVP & Controller | Sale | -5,154 | -37.52%8,582 | $28.66 | $147,714 | View SEC filing | |
| 2023-12-19 | Gottlieb Scott Director | Purchase | +3,000 | +50.00%9,000 | $26.47 | $79,401 | View SEC filing | |
| 2023-05-09 | Gottlieb Scott Director | Purchase | +2,000 | +50.00%6,000 | $38.50 | $77,005 | View SEC filing | |
| 2023-03-17 | DAMICO JENNIFER B. SVP & Controller | Sale | -9,912 | -52.40%9,003 | $40.02 | $396,678 | View SEC filing | |
| 2022-06-08 | DAMICO JENNIFER B. SVP & Controller | Sale | -4,218 | -28.00%10,846 | $53.96 | $227,603 | View SEC filing | |
| 2022-05-17 | DAMICO JENNIFER B. SVP & Controller | Sale | -4,000 | -20.98%15,064 | $50.50 | $202,000 | View SEC filing | |
| 2022-05-16 | SAHNI PAYAL Executive Vice President | Sale | -1,408 | -7.50%17,372 | $49.84 | $70,175 | View SEC filing | |
| 2022-05-13 | Carapezzi William R JR Executive Vice President | Sale | -32,908 | -46.31%38,146 | $50.00 | $1,645,400 | View SEC filing | |
| 2022-05-13 | LANKLER DOUGLAS M Executive Vice President | Sale | -38,273 | -32.69%78,803 | $49.41 | $1,891,069 | View SEC filing | |
| 2022-05-12 | Dolsten Mikael President R&D | Sale | -63,902 | -16.09%333,342 | $49.32 | $3,151,547 | View SEC filing | |
| 2021-12-06 | MACKENZIE ALEXANDER R Executive Vice President | Sale | -41,360 | -32.15%87,280 | $54.26 | $2,244,194 | View SEC filing | |
| 2021-12-06 | JOHNSON RADY A Executive Vice President | Sale | -19,000 | -25.39%55,844 | $53.42 | $1,015,042 | View SEC filing | |
| 2021-11-30 | LANKLER DOUGLAS M Executive Vice President | Sale | -40,000 | -37.62%66,317 | $54.37 | $2,174,786 | View SEC filing | |
| 2021-11-30 | SUSMAN SALLY Executive Vice President | Sale | -44,308 | -33.09%89,575 | $54.52 | $2,415,578 | View SEC filing | |
| 2021-11-15 | Dolsten Mikael President R&D | Sale | -59,664 | -17.57%279,842 | $50.29 | $3,000,647 | View SEC filing | |
| 2021-11-15 | Hwang Angela Group President | Sale | -26,170 | -100.00%1 | $49.60 | $1,298,002 | View SEC filing | |
| 2021-11-12 | YOUNG JOHN D Group President | Sale | -150,000 | -32.42%312,704 | $50.06 | $7,508,732 | View SEC filing | |
| 2021-08-16 | DAMICO JENNIFER B. SVP & Controller | Sale | -1,661 | -14.53%9,769 | $48.30 | $80,226 | View SEC filing | |
| 2021-08-02 | DAMICO JENNIFER B. SVP & Controller | Sale | -2,500 | -17.95%11,430 | $42.86 | $107,150 | View SEC filing | |
| 2021-05-07 | DAMICO JENNIFER B. SVP & Controller | Sale | -2,500 | -15.39%13,748 | $40.82 | $102,050 | View SEC filing | |
| 2020-11-10 | SUSMAN SALLY Executive Vice President | Sale | -43,662 | -28.77%108,096 | $41.94 | $1,831,184 | View SEC filing |
1-25 of 211